The official made the remarks on Tuesday, addressing the 4th International Conference and Exhibition on Iranian Medical Biotech Products and Related Industries (Iran Bio) being held from February 4 to ...

banking on improved demand for its products and services used in developing therapies. However, some life sciences firms such as Danaher (DHR.N), opens new tab have indicated smaller biotech ...

While billions pour into pharmaceutical biotech, officials and experts warn there’s much less private investment in products more relevant to the military, like body armor materials, anti-corrosion ...

banking on improved demand for its products and services used in developing therapies. However, some life sciences firms such as Danaher have indicated smaller biotech clients are still cautious ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Emerging companies in synthetic biology and cell therapy are disrupting traditional healthcare solutions, while agricultural biotechnology is delivering disease-free banana varieties and herbicide ...

that it launched a Biotech and Biomanufacturing Hub to support companies — particularly start-ups and small and medium-sized enterprises (SME) — in bringing innovative products to the European ...

NEW YORK, Jan. 31, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global biotech market size is estimated to grow by USD 805.6 billion from 2025-2029, according to Technavio.

Less than 20 years after the first biopharmaceutical, insulin, was approved, a new generation of products is superseding replacement proteins and enzyme therapies in biotechnology's pipeline.